United States · Bill · S
S. 2901 (116th)
Improving Medicare Beneficiary Access to Innovative Diabetes Technologies Act of 2019
Introduced
19 November 2019
Last action
—
Status
Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S6673)
Sponsors
—
Subjects
Discovery layer
Source updated
3 January 2025
Summary
Improving Medicare Beneficiary Access to Innovative Diabetes Technologies Act of 2019 This bill establishes the Task Force on Innovative Diabetes Technologies and Services to address the accessibility of innovative diabetes technologies and services to Medicare beneficiaries. The bill defines innovative diabetes technologies and services as medical technologies and services for diabetes treatment that are not covered under Medicare. Among other activities, the task force must (1) recommend ways to improve access to innovative diabetes technologies and services through new or alternative payment models and existing policies, and (2) propose changes to foster collaboration between the Food and Drug Administration and the Centers for Medicare & Medicaid Services to streamline approval and coverage.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate · EN · 19 November 2019
Introduced in Senate (PDF)
Introduced in Senate · EN · 19 November 2019
Introduced in Senate
summary · EN · 19 November 2019
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/senate-bill/2901
- Open data entity: https://api.congress.gov/v3/bill/116/s/2901